Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated:  8/29/2017
1609
mi
from 91732
Jackson, MS
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
University of Mississippi
1609
mi
from 91732
Jackson, MS
Click here to add this to my saved trials
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated:  8/29/2017
2440
mi
from 91732
Albany, NY
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Albany Medical College
2440
mi
from 91732
Albany, NY
Click here to add this to my saved trials
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated:  8/29/2017
2035
mi
from 91732
Cleveland, OH
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Cleveland Clinic
2035
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated:  8/29/2017
2184
mi
from 91732
Charleston, SC
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Medical University of South Carolina
2184
mi
from 91732
Charleston, SC
Click here to add this to my saved trials
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated:  8/29/2017
1855
mi
from 91732
Chattanooga, TN
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Memorial Hospital
1855
mi
from 91732
Chattanooga, TN
Click here to add this to my saved trials
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated:  8/29/2017
1853
mi
from 91732
Chattanooga, TN
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Erlanger Hospital
1853
mi
from 91732
Chattanooga, TN
Click here to add this to my saved trials
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated:  8/29/2017
1221
mi
from 91732
Dallas, TX
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Dallas VA Medical Center
1221
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated:  8/29/2017
1357
mi
from 91732
Houston, TX
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
The University Of Texas
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated:  8/29/2017
2273
mi
from 91732
Falls Church, VA
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Inova Health Care Services
2273
mi
from 91732
Falls Church, VA
Click here to add this to my saved trials
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated:  8/29/2017
2269
mi
from 91732
Richmond, VA
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Virginia Commonwealth University
2269
mi
from 91732
Richmond, VA
Click here to add this to my saved trials
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated:  8/29/2017
1654
mi
from 91732
Madison, WI
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
University of Wisconsin
1654
mi
from 91732
Madison, WI
Click here to add this to my saved trials
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated:  8/29/2017
99
mi
from 91732
San Diego, CA
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
University of California, San Diego
99
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated:  8/29/2017
2104
mi
from 91732
Gainesville, FL
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
University of Florida
2104
mi
from 91732
Gainesville, FL
Click here to add this to my saved trials
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated:  8/29/2017
1730
mi
from 91732
Chicago, IL
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Northwestern University
1730
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated:  8/29/2017
1568
mi
from 91732
Saint Louis, MO
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Washington University
1568
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated:  8/29/2017
2435
mi
from 91732
New York, NY
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Mount Sinai School of Medicine
2435
mi
from 91732
New York, NY
Click here to add this to my saved trials
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated:  8/29/2017
1416
mi
from 91732
Fargo, ND
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
Status: Enrolling
Updated: 8/29/2017
Sanford Health
1416
mi
from 91732
Fargo, ND
Click here to add this to my saved trials
Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation
Optimization of NULOJIX® (Belatacept) Usage as a Means of Avoiding CNI and Steroids in Renal Transplantation (CTOT-10)
Status: Enrolling
Updated:  8/29/2017
1919
mi
from 91732
Atlanta, GA
Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation
Optimization of NULOJIX® (Belatacept) Usage as a Means of Avoiding CNI and Steroids in Renal Transplantation (CTOT-10)
Status: Enrolling
Updated: 8/29/2017
Emory University
1919
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation
Optimization of NULOJIX® (Belatacept) Usage as a Means of Avoiding CNI and Steroids in Renal Transplantation (CTOT-10)
Status: Enrolling
Updated:  8/29/2017
1785
mi
from 91732
Birmingham, AL
Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation
Optimization of NULOJIX® (Belatacept) Usage as a Means of Avoiding CNI and Steroids in Renal Transplantation (CTOT-10)
Status: Enrolling
Updated: 8/29/2017
University of Alabama
1785
mi
from 91732
Birmingham, AL
Click here to add this to my saved trials
Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation
Optimization of NULOJIX® (Belatacept) Usage as a Means of Avoiding CNI and Steroids in Renal Transplantation (CTOT-10)
Status: Enrolling
Updated:  8/29/2017
356
mi
from 91732
San Francisco, CA
Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation
Optimization of NULOJIX® (Belatacept) Usage as a Means of Avoiding CNI and Steroids in Renal Transplantation (CTOT-10)
Status: Enrolling
Updated: 8/29/2017
University of California at San Francisco
356
mi
from 91732
San Francisco, CA
Click here to add this to my saved trials
Acid-Base Compensation in Chronic Kidney Disease
Acid-Base Compensation in Chronic Kidney Disease: Measurement and Physiologic Impact
Status: Enrolling
Updated:  8/29/2017
2203
mi
from 91732
Durham, NC
Acid-Base Compensation in Chronic Kidney Disease
Acid-Base Compensation in Chronic Kidney Disease: Measurement and Physiologic Impact
Status: Enrolling
Updated: 8/29/2017
Duke University School of Medicine
2203
mi
from 91732
Durham, NC
Click here to add this to my saved trials
Study of LY3016859 in Participants With Diabetic Nephropathy
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated:  9/7/2017
2117
mi
from 91732
Clearwater, FL
Study of LY3016859 in Participants With Diabetic Nephropathy
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated: 9/7/2017
Innovative Research of West Florida, Inc.
2117
mi
from 91732
Clearwater, FL
Click here to add this to my saved trials
Study of LY3016859 in Participants With Diabetic Nephropathy
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated:  9/7/2017
1299
mi
from 91732
Omaha, NE
Study of LY3016859 in Participants With Diabetic Nephropathy
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated: 9/7/2017
Creighton University Medical Center
1299
mi
from 91732
Omaha, NE
Click here to add this to my saved trials
Study of LY3016859 in Participants With Diabetic Nephropathy
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated:  9/7/2017
2363
mi
from 91732
Bethlehem, PA
Study of LY3016859 in Participants With Diabetic Nephropathy
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated: 9/7/2017
Northeast Clinical Research Center, LLC
2363
mi
from 91732
Bethlehem, PA
Click here to add this to my saved trials
Study of LY3016859 in Participants With Diabetic Nephropathy
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated:  9/7/2017
1855
mi
from 91732
Chattanooga, TN
Study of LY3016859 in Participants With Diabetic Nephropathy
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated: 9/7/2017
Southeast Renal Research Institute
1855
mi
from 91732
Chattanooga, TN
Click here to add this to my saved trials
Study of LY3016859 in Participants With Diabetic Nephropathy
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated:  9/7/2017
1363
mi
from 91732
Lufkin, TX
Study of LY3016859 in Participants With Diabetic Nephropathy
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated: 9/7/2017
TAD Clinical Research
1363
mi
from 91732
Lufkin, TX
Click here to add this to my saved trials
Study of LY3016859 in Participants With Diabetic Nephropathy
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated:  9/7/2017
1188
mi
from 91732
San Antonio, TX
Study of LY3016859 in Participants With Diabetic Nephropathy
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated: 9/7/2017
Renal Associates, PA
1188
mi
from 91732
San Antonio, TX
Click here to add this to my saved trials
Study of LY3016859 in Participants With Diabetic Nephropathy
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated:  9/7/2017
6596
mi
from 91732
Sofia,
Study of LY3016859 in Participants With Diabetic Nephropathy
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated: 9/7/2017
6596
mi
from 91732
Sofia,
Click here to add this to my saved trials
Allopurinol for Renal Transplant Associated Hypertension in Children
Randomized Double-blinded, Placebo-controlled, Cross-over Trial of Allopurinol for the Treatment of Post-renal-transplant Hypertension in Children
Status: Enrolling
Updated:  9/12/2017
1357
mi
from 91732
Houston, TX
Allopurinol for Renal Transplant Associated Hypertension in Children
Randomized Double-blinded, Placebo-controlled, Cross-over Trial of Allopurinol for the Treatment of Post-renal-transplant Hypertension in Children
Status: Enrolling
Updated: 9/12/2017
Texas Children's Hospital
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Immunophenotyping of Peripheral T Cells After T Cell Depletion With Alemtuzumab
Immunophenotyping and Functional Profiles of Peripheral Lymphocytes in Renal Transplant Recipients After T-cell Depletion With Alemtuzumab (Anti-CD52 Monoclonal Antibody)-Potential Implications for Safe Immunosuppressive Minimization
Status: Enrolling
Updated:  9/12/2017
1730
mi
from 91732
Chicago, IL
Immunophenotyping of Peripheral T Cells After T Cell Depletion With Alemtuzumab
Immunophenotyping and Functional Profiles of Peripheral Lymphocytes in Renal Transplant Recipients After T-cell Depletion With Alemtuzumab (Anti-CD52 Monoclonal Antibody)-Potential Implications for Safe Immunosuppressive Minimization
Status: Enrolling
Updated: 9/12/2017
Northwestern Memorial Hospital
1730
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Study of Pharmacokinetics of a Single IV Dose of CB-238,618 in Subjects With Varying Degrees of Renal Impairment Compared to Healthy Subjects
A Phase 1, Non-randomized, Parallel-group, Open-label Study to Characterize the Pharmacokinetics of a Single Intravenous Dose of CB-238,618 in Subjects With Varying Degrees of Renal Impairment Compared to Healthy Subjects
Status: Enrolling
Updated:  9/13/2017
1511
mi
from 91732
Minneapolis, MN
Study of Pharmacokinetics of a Single IV Dose of CB-238,618 in Subjects With Varying Degrees of Renal Impairment Compared to Healthy Subjects
A Phase 1, Non-randomized, Parallel-group, Open-label Study to Characterize the Pharmacokinetics of a Single Intravenous Dose of CB-238,618 in Subjects With Varying Degrees of Renal Impairment Compared to Healthy Subjects
Status: Enrolling
Updated: 9/13/2017
Clinical Research Facility
1511
mi
from 91732
Minneapolis, MN
Click here to add this to my saved trials
Isotonic Solutions and Major Adverse Renal Events Trial in the Medical Intensive Care Unit
Isotonic Solutions and Major Adverse Renal Events Trial in the Medical Intensive Care Unit
Status: Enrolling
Updated:  9/13/2017
1762
mi
from 91732
Nashville, TN
Isotonic Solutions and Major Adverse Renal Events Trial in the Medical Intensive Care Unit
Isotonic Solutions and Major Adverse Renal Events Trial in the Medical Intensive Care Unit
Status: Enrolling
Updated: 9/13/2017
Vanderbilt University Medical Center
1762
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
Isotonic Solutions and Major Adverse Renal Events Trial in the Non-Medical Intensive Care Unit (SMART-SURG)
Isotonic Solutions and Major Adverse Renal Events Trial in Non-Medical Intensive Care Units
Status: Enrolling
Updated:  9/13/2017
1762
mi
from 91732
Nashville, TN
Isotonic Solutions and Major Adverse Renal Events Trial in the Non-Medical Intensive Care Unit (SMART-SURG)
Isotonic Solutions and Major Adverse Renal Events Trial in Non-Medical Intensive Care Units
Status: Enrolling
Updated: 9/13/2017
Vanderbilt University Medical Center
1762
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis
Randomized Study of Standard vs High Amount of Hemodialysis Using Low vs High Flux Dialyzer Membranes for End Stage Renal Disease
Status: Enrolling
Updated:  9/13/2017
2242
mi
from 91732
Rochester, NY
Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis
Randomized Study of Standard vs High Amount of Hemodialysis Using Low vs High Flux Dialyzer Membranes for End Stage Renal Disease
Status: Enrolling
Updated: 9/13/2017
University of Rochester School of Medicine
2242
mi
from 91732
Rochester, NY
Click here to add this to my saved trials
Pharmacokinetics of Single-Dose Oral Ranolazine in Hemodialysis Patients
Pharmacokinetics of Single-Dose Oral Ranolazine in Hemodialysis Patients
Status: Enrolling
Updated:  9/13/2017
1934
mi
from 91732
Ann Arbor, MI
Pharmacokinetics of Single-Dose Oral Ranolazine in Hemodialysis Patients
Pharmacokinetics of Single-Dose Oral Ranolazine in Hemodialysis Patients
Status: Enrolling
Updated: 9/13/2017
University of Michigan Hospital
1934
mi
from 91732
Ann Arbor, MI
Click here to add this to my saved trials
2436
mi
from 91732
Brooklyn, NY
Parkside Hemodialysis
2436
mi
from 91732
Brooklyn, NY
Click here to add this to my saved trials
Saline Against Lactated Ringers or Plasmalyte in the Emergency Department
Saline Against Lactated Ringers or Plasmalyte in the Emergency Department (SaLt-ED)
Status: Enrolling
Updated:  9/14/2017
1762
mi
from 91732
Nashville, TN
Saline Against Lactated Ringers or Plasmalyte in the Emergency Department
Saline Against Lactated Ringers or Plasmalyte in the Emergency Department (SaLt-ED)
Status: Enrolling
Updated: 9/14/2017
Vanderbilt University Medical Center Adult Emergency Department
1762
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated:  9/17/2017
1785
mi
from 91732
Birmingham, AL
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated: 9/17/2017
University of Alabama at Birmingham School of Medicine
1785
mi
from 91732
Birmingham, AL
Click here to add this to my saved trials
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated:  9/17/2017
344
mi
from 91732
Phoenix, AZ
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated: 9/17/2017
Banner Good Samaritan Transplant
344
mi
from 91732
Phoenix, AZ
Click here to add this to my saved trials
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated:  9/17/2017
20
mi
from 91732
Los Angeles, CA
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated: 9/17/2017
Cedars-Sinai Health System/Center for Kidney Diseases and Transplantation
20
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated:  9/17/2017
25
mi
from 91732
Los Angeles, CA
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated: 9/17/2017
University of California at Los Angeles
25
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated:  9/17/2017
356
mi
from 91732
San Francisco, CA
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated: 9/17/2017
University of California at San Francisco
356
mi
from 91732
San Francisco, CA
Click here to add this to my saved trials
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated:  9/17/2017
1730
mi
from 91732
Chicago, IL
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated: 9/17/2017
Northwestern University
1730
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated:  9/17/2017
1608
mi
from 91732
Springfield, IL
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated: 9/17/2017
Southern Illinois University
1608
mi
from 91732
Springfield, IL
Click here to add this to my saved trials
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated:  9/17/2017
1791
mi
from 91732
Indianapolis, IN
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated: 9/17/2017
Indiana University
1791
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated:  9/17/2017
1528
mi
from 91732
Iowa City, IA
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated: 9/17/2017
University of Iowa Hospitals and Clinics
1528
mi
from 91732
Iowa City, IA
Click here to add this to my saved trials
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated:  9/17/2017
2614
mi
from 91732
Portland, ME
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated: 9/17/2017
Maine Medical Center
2614
mi
from 91732
Portland, ME
Click here to add this to my saved trials
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated:  9/17/2017
2301
mi
from 91732
Baltimore, MD
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated: 9/17/2017
University of Maryland Medical Center
2301
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated:  9/17/2017
2578
mi
from 91732
Boston, MA
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated: 9/17/2017
Brigham and Women's Hosp
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated:  9/17/2017
1953
mi
from 91732
Ann Arbor, MI
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated: 9/17/2017
University of Michigan Medical Center
1953
mi
from 91732
Ann Arbor, MI
Click here to add this to my saved trials